13D/13G Filings - Equillium Inc. (EQ)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-14
9:50 pm
Purchase
2024-09-30 13G Equillium, Inc.
EQ
Decheng Capital Management IV (Cayman) LLC 5,733,021
15.600%
5,733,021increase
(New Position)
Filing
History
2024-01-19
06:03 am
Purchase
2023-12-31 13G Equillium, Inc.
EQ
TAKEDA PHARMACEUTICAL CO LTD 1,842,977
5.200%
1,842,977increase
(New Position)
Filing
History
2023-03-03
09:27 am
Sale
2023-02-28 13G Equillium, Inc.
EQ
Victory Capital Management, Inc. 1,352,210
3.930%
-2,840,444decrease
(-67.75%)
Filing
History
2023-01-31
09:41 am
Purchase
2022-12-31 13G Equillium, Inc.
EQ
Victory Capital Management, Inc. 4,192,654
12.200%
66,987increase
(+1.62%)
Filing
History
2022-02-14
11:57 am
Purchase
2021-12-31 13G Equillium, Inc.
EQ
Decheng Capital Management III (Cayman) LLC 4,447,308
15.130%
4,447,308increase
(New Position)
Filing
History
2022-02-01
12:39 pm
Purchase
2021-12-31 13G Equillium, Inc.
EQ
Victory Capital Management, Inc. 4,125,667
14.040%
1,327,535increase
(+47.44%)
Filing
History
2021-02-16
5:21 pm
Purchase
2021-02-05 13D Equillium, Inc.
EQ
Decheng Capital Global Life Sciences Fund IV, L.P. 5,733,021
19.700%
5,733,021increase
(New Position)
Filing
History
2021-02-03
09:34 am
Purchase
2020-12-31 13G Equillium, Inc.
EQ
Victory Capital Management, Inc. 2,798,132
11.320%
564,408increase
(+25.27%)
Filing
History